Bomi Italia S.p.A.

– PRESS RELEASE –

Approval of six month results to 30 June 2018

Consolidated Value of Production of Euro 62.1 million (Euro 67.2 million at constant 2017 Euro/foreign currency exchange rates 2017) compared with Euro 58.6 million at 30 June 2017

Positive Consolidated Gross Operating Profit (EBITDA) of Euro 5.5 million (Euro 6.3 million at constant 2017 Euro/foreign currency exchange rates), net of extraordinary and non-recurring items, compared with Euro 5.6 million at 30 June 2017

Consolidated Net Profit of Euro 1.2 million (Euro 1.5 million at constant 2017

Euro/foreign currency exchange rates), of which Net Profit attributable to Bomi Group is Euro 1.2 million (Euro 1.5 million at constant 2017 Euro/foreign currency exchange rates) compared with Euro 1.6 million, of which Net Profit attributable to

Bomi Group was Euro 0.9 million at 30 June 2017

Consolidated Net Financial Position of Euro 29.5 million

Consolidated Net Equity of Euro 12.6 million

Vaprio d’Adda, 28 September 2018 – Bomi Italia S.p.A. (“Bomi” or the “Company” or the

“Issuer”), Parent Company of the Bomi Group, a world leader in the biomedical logistics sector

and in the management of high technology healthcare products, which is listed on the multilateral

trading platform of AIM Italia / Alternative Capital Market, regulated and managed by Borsa

Italiana S.p.A., announces that the Board of Directors has today approved the consolidated six

month financial report to 30 June 2018 prepared in accordance with international accounting

principles (IAS/IFRS).

The Chairman of the Board of Directors Giorgio Ruini stated:

“In the first half of 2018 Bomi Group confirms the growth trend through both organically and by

acquisition, undertaken in recent years and planned in the Business Plan, despite the extremely

volatile trend of foreign currencies in the second quarter of 2018. We are continuing our strong

commitment to a focused commercial policy and the creation of synergies in the new businesses

acquired in the past two years. We therefore believe that we are on the right path but there is much

more that we can still do to bring the Group to ambitious goals that we want to pursue.”

Principal economic results of the Group:

* Reclassified Consolidated Income Statement at 30 June 2018 at constant exchange rates first half 2017.

Consolidated operating revenues rose by 5.9% compared with the same period of the previous

year. At constant Euro/foreign exchange rates, growth would have been 14.8%, of which 5.5% is

attributable to internal growth and the remaining 9.3% to the inclusion of the company De Salute

S.r.l., a company specialising in biotech products, pharmaceutical and Healthcare technologies

logistics, which was acquired by Bomi in January 2018. The consolidated operating revenues at

30 June 2018 were therefore about 1.5% higher than the figure projected in the Group’s 2018 –

2020 Business Plan (Plan) which was approved and publicly announced on 22 January 2018.

The following figures show a breakdown of revenues by geographical area which confirm the

balancing of the share of revenues generated in Euro and revenues in foreign currencies which

allows the Group to mitigate the effects of volatility and macro-economic fluctuations on its results:

* Revenues at 30 June 2018 at constant exchange rates first half 2017.

The Brazilian company reported an increase in operating revenues in local currency of 3.8% which

was adversely affected on conversion into Euro by the trend of exchange rates. The growth in the

revenues of the Italian companies was due to the inclusion in the Group of the recently acquired De

Salute. The revenues of the subsidiaries in the rest of Latin America grew strongly as a result of

the inclusion of important new clients at the end of 2017.

€/1000 30/06/2018* 30/06/2018 30/06/2017 Change

Value of production 67.291 100,0% 62.089 100,0% 58.640 100,0% 5,9%

Services costs and others (45.417) -67,5% (42.257) -68,1% (38.528) -65,7% 9,7%

Personnel Costs (14.536) -21,6% (13.298) -21,4% (13.100) -22,3% 1,5%

Other operating charges (1.056) -1,6% (1.040) -1,7% (1.378) -2,4% -24,6%

Gross operating profit (EBITDA) 6.282 9,3% 5.495 8,8% 5.634 9,6% -2,5%

Amortization, depreciation and writedowns (2.721) -4,0% (2.549) -4,1% (2.098) -3,6% 21,5%

Extraordinary Income (costs) (861) -1,3% (758) -1,2% (478) -0,8% 58,6%

Net operating profit (EBIT) 2.700 4,0% 2.188 3,5% 3.057 5,2% -28,4%

Financial Income (costs) (914) -1,4% (751) -1,2% (604) -1,0% 24,3%

Net profit before tax 1.786 2,7% 1.437 2,3% 2.454 4,2% -41,4%

Taxes (276) -0,4% (218) -0,4% (890) -1,5% -75,5%

Net result 1.510 2,2% 1.219 2,0% 1.563 2,7% -22,0%

Net result attributable to non-controlling interests 54 0,1% 47 0,1% 597 1,0% -92,1%

Net result attributable to the Group 1.456 2,2% 1.172 1,9% 966 1,6% 21,3%

€/00030/06/2018*

% sul

tot30/06/2018

% sul

tot30/06/2017

% sul

tot18 vs 17

Italy 22.778 33,8% 22.775 36,7% 18.186 31,0% 25,2%

Rest of Europe 7.816 11,6% 7.816 12,6% 7.640 13,0% 2,3%

Brazil 24.050 35,7% 19.995 32,2% 23.162 39,5% -13,7%

Rest of Latam 8.246 12,3% 7.719 12,4% 4.846 8,3% 59,3%

Turkey 2.781 4,1% 2.210 3,6% 2.716 4,6% -18,6%

China 1.354 2,0% 1.307 2,1% 1.789 3,1% -27,0%

Other 267 0,4% 267 0,4% 301 0,5% -11,2%

Total 67.291 100,0% 62.089 100,0% 58.640 100,0% 5,9%

The Consolidated Operating Margin at 30 June 2018 reclassified before depreciation, provisions

and excluding extraordinary and non-recurring costs rose by 11.5% at constant 2017 Euro/foreign

currency exchange rates compared with the same period of 2017. Non-recurring and extraordinary

costs relate primarily to about Euro 79 thousand of una tantum costs incurred in the move to new

operating headquarters in Italy, about Euro 362 thousand relates to the costs pertaining to the first

half 2018 regarding the non-compete agreement included in the acquisition of the minority interest

of the Brazilian company in November 2017, about Euro 171 thousand relates to staff reduction

incentives in Italy, Turkey and also in Brazil, where, following the aforementioned acquisition, the

process of operational reorganisation is continuing, and finally for other non-recurring expenses.

The Group is continuing its commitment to the realisation of synergies aimed at improving

profitability. Following the acquisition of the Italian company De Salute, the Group sought to

achieve synergies relating in particular to transport services. The actions undertaken during the

course of the first half will make more contribution to profitability in the second half of the year.

The Consolidated Operating Margin at 30 June 2018 is also about 3.7% higher than that

projected in the 2018 -2020 Plan.

The net profit at constant 2017 Euro/foreign currency exchange rates is substantially in line with

the profit in the first half of 2017 while the net profit attributable to the Group rose by 21.3%

compared with the first half of 2017, which equates to growth of 50.8% at constant 2017 exchange

rates. The growth in Group net profit is also related to the strategy of consolidation of the

minorities implemented by Bomi Group.

The following illustrates the change in the net financial position (NFP) at 30 June 2018,

characterised primarily by:

- Investments of Euro 3.2 million made in the first half 2018 relating to investments made as part

of management operations to set up and maintain the operating premises, while Euro 4.6 million

relates to M&A transactions for the acquisition of De Salute and the acquisition of the minority

interests in the subsidiaries in Colombia and Holland.

- In the first half 2018 Bomi Italia S.p.A. also successfully completed a Capital Increase which was

fully subscribed, and which closed on 1 June 2018, raising a total of Euro 4.7 million (net of

related expenses).

- The net financial position at 30 June 2018 of the recently acquired De Salute company was Euro

1.3 milion.

- The change in working capital is partly attributable to the effect of the growth in revenues and

also to a natural increase in “Other assets” in the first half of each year primarily relating to the

inclusion of costs which have not yet been incurred but which have a financial impact on the first

half, such as prepaid rent and insurance of the warehouses.

The breakdown of the net financial position at 30 June 2018 was as follows:

The following table shows the maturities of the aforementioned non-convertible financial debt:

It should be noted from the illustration that all repayments until 2020 are completely covered by

the liquidity available at 30 June 2018.

It should be noted that the acquisition of the minorities done in 2017 and first half 2018, in

particular the acquisition of 45% of Brazilian subsidiary in November 2017, generated a negative

difference on net equity of Euro 13,9 million, because in accordance with IFRS 3, the goodwill

generated by the acquisition of a non-controlling interest is recognised as a reduction of net equity

and not as assets.

Principal events occurring prior to 30 June 2018

It should be noted that at 23 January 2018 the parent company acquired 100% of the share capital

of De Salute S.r.l. (“De Salute”), a company which operates in logistics and services for the

pharmaceutical sector (biotech and generics) located at Soresina (Cremona). This acquisition,

completed for a consideration of Euro 2,450,000 as well as an earn-out component (up to a

maximum further Euro1,600,000) tied to the achievement of certain performance parameters to be

calculated by 31 March 2019. The Bomi Group is continuing its strategy of consolidation in Europe,

expanding the offer of its services in a market with prospects for increasing value added and which

provides the Group with significant synergy opportunities in transport and additional potential for

cross-selling.

During the first half 2018, the Group also pursued its strategy to consolidate minorities by

acquiring an additional share of 10% of the share capital of “Biomedical Distribution Colombia SL

LTDA” (“Bomi Colombia”), now 90% owned by Bomi Group and the residual shareholdings in

Biocarrier SAS (Colombian transport company) and Ritmo Holding B.V..

On 30 April 2018 the Extraordinary Meeting of Shareholders of the Parent Company approved a

capital increase involving the issue of 1,666,265 new shares, offered in option to holders of pre-

emption rights at a price of Euro 3.00 each (of which Euro 2.55 was share price premium) for a

total value of a maximum of Euro 4,998,795.00. This capital increase was fully subscribed and

closed on 1 June 2018.

Following this operation, the fully paid up share capital of Bomi Italia S.p.A. is Euro 5,904,497.10

subdivided into no. 16,893,916 ordinary share, with no express nominal value.

Principal events occurring after 30 June 2018

It should be noted that on 18 July 2018 Bomi acquired 100% of the share capital of “Farma

Logistica S.r.l.”, a company which operates in logistics and transport for the healthcare sector in

Central-Southern Italy located at Somma Vesuviana (Naples). This acquisition, for a consideration

of Euro 2,900,000, as well as an earn-out component (up a maximum further Euro 1,100,000) tied

to the achievement of certain performance parameters to be calculated by 18 July 2021, will allow

Bomi Group to achieve significant synergies in its transport network and additional potential for

cross-selling, and is in line with its strategy of consolidation in Europe.

The company BDO S.p.A., as legal independent auditor of the financial statements expressed a

positive judgement about the abbreviated six-month Consolidated Financial Statements to 30 June

2018.

The Consolidated Six Month Financial Report to 30 June 2018 will be available on the website

www.bomigroup.com, in the section Investor Relations, Financial Reports, in accordance with the

terms and means required by the Issuers’ Regulations AIM Italia.

___________________________________________________________________________________________________

Bomi Italia S.p.A. is the Parent Company of Bomi Group, a world leader in the biomedical logistics sector and

in the management of high technology healthcare products. It was one of the first companies to receive the

“Elite” certificate issued by Borsa Italiana.

Bomi Group’s activities are concentrated in the integrated logistics sector and offer a wide range of logistics

services in outsourcing to companies operating in the healthcare sector, managing distribution of medical

equipment, pharmaceuticals, in-vitro diagnostic equipment, reagents and implant products.

Bomi Group’s portfolio of about 100 clients includes some of the world’s top healthcare companies (such as the

leading pharmaceutical companies and producers of healthcare devices) as well as small and medium sized

companies operating at a global level in the biomedical, diagnostics and biotech industries. Bomi Group

currently has about 1,325 employees and operates through subsidiary companies and associated companies in

Europe, South America, China and the United States and its services are also provided, through strategic

alliances with local partners.

ISIN Ordinary Share Code: IT0005108748 – Ordinary Share Ticker: BOMI

ISIN Convertible Bond Code: IT0005114480 – Convertible Bond Ticker: BOMI20

For further information.

Bomi Italia S.p.A. ● IR Top BPER Banca S.p.A. ●

Investor Relations IR & Financial Communication Nominated Adviser tel: +3903962781313 Tel. +39 45473883 tel: +390512756537 e.mail: investorrelator@bomigroup.com Email: @ir@irtop.com e.mail: bomi@bper.it

Attachments

* Reclassified Consolidated Income Statement at 30 June 2018 at constant exchange rates first half 2017.

Reclassified Income Statement 30/06/2018* 30/06/2018 30/06/2017

Value of production 67.291.342 62.089.016 58.639.564

Services costs and others (45.417.424) (42.257.119) (38.527.779)

Personnel Costs (14.535.602) (13.297.637) (13.099.661)

Other operating charges (1.056.129) (1.039.507) (1.378.261)

Gross operating profit (EBITDA) 6.282.187 5.494.752 5.633.863

Amortization, depreciation and writedowns (2.721.076) (2.549.128) (2.098.468)

Extraordinary Income (costs) (861.271) (757.882) (477.958)

Net operating profit (EBIT) 2.699.840 2.187.742 3.057.437

Financial Income (costs) (913.557) (750.600) (603.843)

Net profit before tax 1.786.283 1.437.142 2.453.594

Taxes (276.109) (217.849) (890.330)

Net result 1.510.174 1.219.293 1.563.264

Net result attributable to non-controlling interests 53.831 47.369 597.376

Net result attributable to the Group 1.456.343 1.171.924 965.888

Consolidation Financial Statement Bomi Group

Reclassified Balance Sheet 30/06/2018 31/12/2017 Change

Net Intangible Assests 17.504.868 17.748.856 (243.988)

Net Tangible Assests 23.951.319 17.325.173 6.626.145

Long-term investments 299.653 280.653 19.000

Other receivables falling due after one year 870.946 1.439.193 (568.247)

Total Intangibles, Tangible assets and Long-

term investments 42.626.785 36.793.875 5.832.910

Inventories 1.107.740 198.556 909.184

Trade accounts receivable 23.837.112 17.674.383 6.162.729

Other receivables 5.004.656 3.969.155 1.035.501

Accrued income and prepaid axpenses 2.238.141 2.073.864 164.277

Total Short-Term assets 32.187.650 23.915.959 8.271.690

Accounts payable to suppliers: 23.352.340 17.677.558 5.674.782

Taxes payable and social security contributions 2.614.649 2.400.073 214.576

Other liabilities 4.016.280 3.710.976 305.304

Accrued expenses and deferred income 176.951 499.684 (322.733)

Total short term liabilities 30.160.220 24.288.292 5.871.929

Net Working Capital 2.027.429 (372.332) 2.399.762

Reserve for employee termination indemnity 1.574.073 1.495.267 78.806

Taxes payable and social security contributions

falling due after one year 774.379 515.752 258.627

Other liabilities falling due after one year 203.803 41.253 162.550

Total long term liabilities 2.552.255 2.052.272 499.984

Invested Capital 42.101.959 34.369.271 7.732.688

Shareholders' Equity (12.566.240) (8.821.431) (3.744.809)

Net Financial Position falling due after one year (50.815.401) (30.570.655) (20.244.746)

Net Financial Position falling due within one year 21.279.683 5.022.816 16.256.867

Equity and Net Financial Position (42.101.959) (34.369.271) (7.732.688)

Consolidation Financial Statement Bomi Group